12-2567648-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000719.7(CACNA1C):c.1749C>T(p.Tyr583Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 synonymous
NM_000719.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.106
Publications
1 publications found
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 12-2567648-C-T is Benign according to our data. Variant chr12-2567648-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 416879.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.106 with no splicing effect.
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.1839C>T | p.Tyr613Tyr | synonymous_variant | Exon 13 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.1914C>T | p.Tyr638Tyr | synonymous_variant | Exon 14 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.1839C>T | p.Tyr613Tyr | synonymous_variant | Exon 13 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.1839C>T | p.Tyr613Tyr | synonymous_variant | Exon 13 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.1839C>T | p.Tyr613Tyr | synonymous_variant | Exon 13 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.1839C>T | p.Tyr613Tyr | synonymous_variant | Exon 13 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.1824C>T | p.Tyr608Tyr | synonymous_variant | Exon 14 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.1824C>T | p.Tyr608Tyr | synonymous_variant | Exon 14 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.1740C>T | p.Tyr580Tyr | synonymous_variant | Exon 13 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.1749C>T | p.Tyr583Tyr | synonymous_variant | Exon 13 of 46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000480911.6 | n.*356C>T | non_coding_transcript_exon_variant | Exon 11 of 27 | 5 | ENSP00000437936.2 | ||||
CACNA1C | ENST00000480911.6 | n.*356C>T | 3_prime_UTR_variant | Exon 11 of 27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
152238
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000202 AC: 5AN: 246992 AF XY: 0.0000224 show subpopulations
GnomAD2 exomes
AF:
AC:
5
AN:
246992
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460806Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726538 show subpopulations
GnomAD4 exome
AF:
AC:
10
AN:
1460806
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
726538
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33470
American (AMR)
AF:
AC:
0
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26096
East Asian (EAS)
AF:
AC:
0
AN:
39686
South Asian (SAS)
AF:
AC:
0
AN:
85920
European-Finnish (FIN)
AF:
AC:
0
AN:
53346
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
10
AN:
1111516
Other (OTH)
AF:
AC:
0
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74382
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41474
American (AMR)
AF:
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
68042
Other (OTH)
AF:
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 05, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Long QT syndrome Benign:1
Mar 17, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.